Core A contains a Becton-Dickinson DiVa cell sorter and LSR analyzer. The DiVa is a 13-parameter 4-way5-laser cell sorter. The LSR has excitation lines in the ultraviolet, visible and red spectra. The Core Leaderwas recently awarded (1/1/05) a SIG to build a 6-laser, 20-detector LSR-2 which will be available for thisprogram. For Project 1 (Sykes), Core A will be used for 9-color flow cytometry studies required to assessactivation and memory markers on GVH-reactive and non-reactive T cell subsets identified with specificmarkers, for CFSE studies, and for sorting of T cell subsets to be adoptively transferred from lymphoid andnon-lymphoid tissues of GVHD mice and delayed DLI recipients. Project 2 (Yang) will investigate themechanisms by which IFN-gamma separates GVL effects from GVHD-inducing activity of donor CDS T cellsin allogeneic HCT recipients. The program will need a cell sorter about 2 days/month to purify donor fromrecipient mouse cells, obtained from approximately 30 mice/yr, for transplantation. For Project 3 (Sachs),Core A will be used for the specific T-cell subset depletion of the donor DLI inoculum and the separation ofdonor-type and host-type T-cells from PBMC of chimeric recipients at monthly intervals, following HCT forthe purpose of in vitro and in vivo mechanistic studies of regulatory cells. For Project 4 (Scadden), the resultof PTH administration on CD34+ cell yields in patients treated with G-CSF mobilization will be monitored.The immune reconstitution of post-transplant patients treated with PTH will also be monitored. For themurine studies related to Project 4, Core A will assess and separate lymphocytes based upon T-celldifferentiation antigens and MHC specificity. Approximately 20 sorts and 45 analyses will be needed for thisproject.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA111519-01A2
Application #
7158103
Study Section
Subcommittee G - Education (NCI)
Project Start
2006-07-01
Project End
2011-06-30
Budget Start
2006-09-12
Budget End
2007-07-31
Support Year
1
Fiscal Year
2006
Total Cost
$35,500
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Sykes, Megan (2018) Immune monitoring of transplant patients in transient mixed chimerism tolerance trials. Hum Immunol 79:334-342
La Muraglia 2nd, G M; O'Neil, M J; Madariaga, M L et al. (2015) A novel approach to measuring cell-mediated lympholysis using quantitative flow and imaging cytometry. J Immunol Methods 427:85-93
Li, Hao Wei; Andreola, Giovanna; Carlson, Alicia L et al. (2015) Rapid Functional Decline of Activated and Memory Graft-versus-Host-Reactive T Cells Encountering Host Antigens in the Absence of Inflammation. J Immunol 195:1282-92
Matar, Abraham J; Patil, Aarti R; Al-Musa, Ahmad et al. (2015) Effect of Irradiation on Incidence of Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation in Miniature Swine. Biol Blood Marrow Transplant 21:1732-8
Sykes, M (2015) Immune tolerance in recipients of combined haploidentical bone marrow and kidney transplantation. Bone Marrow Transplant 50 Suppl 2:S82-6
Duran-Struuck, Raimon; Huang, Christene A; Orf, Katherine et al. (2015) Miniature Swine as a Clinically Relevant Model of Graft-Versus-Host Disease. Comp Med 65:429-43
Buchan, Sarah; Manzo, Teresa; Flutter, Barry et al. (2015) OX40- and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescence. J Immunol 194:125-133
Leonard, D A; Kurtz, J M; Mallard, C et al. (2014) Vascularized composite allograft tolerance across MHC barriers in a large animal model. Am J Transplant 14:343-55
Wang, Hui; Yang, Yong-Guang (2014) The complex and central role of interferon-? in graft-versus-host disease and graft-versus-tumor activity. Immunol Rev 258:30-44
Wang, Yi; Wang, Hui; Xia, Jinxing et al. (2013) Activated CD8 T cells acquire NK1.1 expression and preferentially locate in the liver in mice after allogeneic hematopoietic cell transplantation. Immunol Lett 150:75-8

Showing the most recent 10 out of 36 publications